Physician profile
Sandra M Kellum
NPI 1669881397
$1,047.81
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.12 · 2021: $177 · 2022: $61.68 · 2023: $370 · 2024: $266 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $798.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $417.46 | 2021-2024 | Nucala, Bexsero |
| Corium, LLC | $181.21 | 2023-2024 | Azstarys |
| Cranial Technologies, INC | $96.44 | 2021-2025 | Doc Band |
| Pfizer INC. | $63.35 | 2021 | |
| Merck Sharp & Dohme LLC | $59.22 | 2020-2025 | Gardasil 9, Rotateq, Enflonsia |
| Takeda Pharmaceuticals U.S.A., INC. | $47.00 | 2021 | |
| Sanofi Pasteur INC. | $35.59 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $27.36 | 2025 | |
| Alk-Abello, INC | $26.28 | 2025 | Neffy |
| Ars Pharmaceuticals Operations, INC. | $24.90 | 2025 | Neffy |
| Ceribell, INC. | $24.41 | 2025 | Pocket Eeg Device |
| Ultragenyx Pharmaceutical INC. | $17.37 | 2022 | |
| Abbvie INC. | $14.23 | 2022 | |
| Qiagen, LLC | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Kellum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.